Citations

Clear

10 citation(s) found for "Snyder, James".

A framework for using DNA methylation-based modelling for the clinical management of cranial meningioma
Landry, Alexander , Wang, Justin Z. , Patil, Vikas, Ajisebutu, Andrew, Gui, Chloe , Yefet, Leeor, Mamatjan, Yasin , Wei, Qingxia , Singh, Olivia, Mansouri, Sheila , Ehret, Felix , Capper, David , Cohen-Gadol, Aaron A, Behling, Felix , Sloan, Andrew E. , Chambless, Lola B. , Makarenko, Serge , Yip, Stephen , Tsang, Derek S. , Gao, Andrew , Aldape, Kenneth , Nassiri, Farshad , Zadeh, Gelareh , Santarius, Thomas , Selman, Warren R., Couce, Marta , Wen, Patrick Y. , Walbert, Tobias , Felicella, Michelle M. , Brodie, Chaya , Snyder, James P., Saladino, Andrea , Schichor, Christian , Tonn, Jörg‐Christian, Goldbrunner, Roland , Timmer, Marco , Schimdt, Nils Ole, Jenkinson, Michael D. , Millward, Christopher P. , Islim, Abdurrahman I. , Fl, Behling, Santacroce, Antonio , Schittenhelm, Jens , Raleigh, David R. , Butowski, Nicholas , Westphal, Manfred , Lamszus, Katrin , Mawrin, Christian , Kurz, Sylvia C. , Zada, Gabriel , Yip, Stephen, Zherebitskiy, Viktor, Hnenny, Luke, Dunn, Ian F. , Moliterno, Jennifer , McDermott, Michael , Vogelbaum, Michael A. , Aldape, Kenneth, Alkividias, Tzannis, Short, Susan , Bos, Eelke M. , Dincer, Alper , Paßlack, Peter, Ehret, Felix, Lopez, Clara, Arvaniti, Christina , Benjamin, Carolina , Jackson, Christina , Jeyaretna, Sanjeeva, Scartoni, Daniele , Amelio, Dante , Ivanidze, Jana , Kien, Duong Trung, Millareschavez, Miguel, AlThgafi, Malak, LeRhun, Emilie, Smee, Robert, Muirhead, William , Molina, Eric Suero, Julius, Vitowanu, Chen, J., Mrugała, Maciej M. , Castro, Ana Valeria , Mamatjan, Yasin , Capper, David , Tatagiba, Marcos , Barnholtz-Sloan, Jill S , Yip, Stephen , Aldape, Kenneth , Zadeh, Gelareh , Short, Susan C , Yefet, Leeor S. , Ellenbogen, Yosef , Liu, Jeff , Singh, Olivia , Tabatabai, Ghazaleh , Tatagiba, Marcos , Barnholtz‐Sloan, Jill S. , Mansouri, Alireza , Brastianos, Priscilla K. , Shih, Helen A. , Bi, Wenya Linda , Huang, Raymond Y. , Wen, Patrick Yung , Lee, Ian , Malta, Tathiane Maistro , Castro, Ana Valéria , Noushmehr, Houtan , DiMeco, Francesco , Pollo, Bianca , Kaufmann, Timothy J. , Lachance, Daniel Honore , Giannini, Caterina , Galanis, Evanthia , Raghunathan, Aditya , Hanemann, C. Oliver , Au, Karolyn , Galldiks, Norbert , Herold‐Mende, Christel C. , Sahm, Felix , Jungk, Christine , Jungwirth, Gerhard , Deimling, Andreas von , Drummond, Katharine Jann , Morokoff, Andrew P. , Renovanz, Mirjam , Fougère, Christian la , Perry, Arie , Ricklefs, Franz , Horbinski, Craig , Ng, Ho‐Keung , Snuderl, Matija , Sulman, Erik P. , Cohen‐Gadol, Aaron , Javadpour, Mohsen , Fountain, Daniel Mark , Mathiesen, Tiit Illimar , Pathmanaban, Omar Nathan , Boutros, Paul C. , Fountas, Konstantinos N. , Walsh, Kyle M. , Carvalho, Bruno , Maas, Sybren L. N. , Deng, Maximilian Y. , Mehta, Minesh P. , Odia, Yazmín , Everson, Richard G. , Balogun, James , Calabrese, Evan , Karschnia, Philipp , Teske, Nico , Fariselli, Laura , Greve, Tobias , Ivan, Michael E , Palmer, Joshua D. , Ostrom, Quinn T. , Youngblood, Mark W. , Emerson, Sam, Weller, Michael , Martínez-Pérez, Rafael , Mukherjee, Raj, Cervio, Andrés , Turner, Clinton P. , Chen, Jiawei, Karmur, Brij S. , Neth, Bryan J.

Mayo Clinic

Neuro-Oncology | November 15, 2025 | Volume: 28 | Issue: 2 | Pages: 430-439

10.1093/neuonc/noaf237 | PMID 41259653 Get It

Abstract Background DNA methylation profiling can be used to robustly predict postsurgical outcomes and response to radiotherapy (RT) for meningioma patients. To allow for seamless integration of these complementary models into clinical practice, a practical framework is needed. Methods We leveraged a cohort of nearly 2000 surgically-treated meningiomas with DNA methylation profiling and clinical outcomes data. Existing methylation-based prediction models were dichotomized to yield four risk groups: low and high recurrent risk, each with RT sensitive and resistant subgroups. Risk groups were correlated with progression-free survival in the context of existing biomarkers including extent of resection and WHO grade. Results We first demonstrated that all risk groups benefit from gross total resection. All “high-risk, RT sensitive” tumors (n = 306, 15.7%) also benefited from adjuvant RT: after GTR, median PFS increased from 4.68 (4.13-9.48) years to not reached (P = .003); after subtotal resection (STR), from 2.12 (1.59-3.02) to 4.09 (3.41-not reached) years (P = .004). “Low-risk, RT sensitive cases” (n = 1207, 61.8%) also benefited from RT after STR (median PFS 7.39 (6.66-12.8) vs. 16.53 (10.35-not reached) years, P = .03), suggesting that RT be considered in these patients. Neither “low-risk RT resistant” (n = 84, 4.3%) nor “high-risk RT resistant” (n = 356, 18.2%) cases benefited from RT, and the latter group was associated with universally poor outcomes. Conclusions We identify methylation-defined risk groups of meningioma for which additional benefit is gained from adjuvant RT, leading to a clinical decision-making framework for straightforward integration of molecular models into clinical practice.
Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2024 Update by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)
Binnicker, Matthew J. , Campbell, Sheldon , Chapin, Kimberle C. , Gonzalez, Mark D. , Harrington, Amanda, Jerris, Robert C. , Kehl, Sue C., Pritt, Bobbi S. , Richter, Sandra S. , Robinson-Dunn, Barbara, Snyder, James W. , Telford, Sam R. , Theel, Elitza S. , Thomson, Richard B., Weinstein, Melvin P., Yao, Joseph D. , Pritt, Bobbi S , Miller, J. Michael , Carroll, Karen C. , Leal, Sixto M. , Patel, Robin

Mayo Clinic

Clinical Infectious Diseases | February 23, 2024 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1093/cid/ciae104 | PMID 38442248 Get It

Abstract The critical nature of the microbiology laboratory in infectious disease diagnosis calls for a close, positive working relationship between the physician and the microbiologists who provide enormous value to the healthcare team. This document, developed by experts in both adult and pediatric laboratory and clinical medicine, provides information on which tests are valuable and in which contexts, and on tests that add little or no value for diagnostic decisions. Sections are divided into anatomic systems, including Bloodstream Infections and Infections of the Cardiovascular System, Central Nervous System Infections, Ocular Infections, Soft Tissue Infections of the Head and Neck, Upper Respiratory Infections, Lower Respiratory Tract Infections, Infections of the Gastrointestinal Tract, Intraabdominal Infections, Bone and Joint Infections, Urinary Tract Infections, Genital Infections, and Skin and Soft Tissue Infections; or into etiologic agent groups, including arboviral Infections, Viral Syndromes, and Blood and Tissue Parasite Infections. Each section contains introductory concepts, a summary of key points, and detailed tables that list suspected agents; the most reliable tests to order; the samples (and volumes) to collect in order of preference; specimen transport devices, procedures, times, and temperatures; and detailed notes on specific issues regarding the test methods, such as when tests are likely to require a specialized laboratory or have prolonged turnaround times. In addition, the pediatric needs of specimen management are also addressed. There is redundancy among the tables and sections, as many agents and assay choices overlap. The document is intended to serve as a reference to guide physicians in choosing tests that will aid them to diagnose infectious diseases in their patients.
Consensus core clinical data elements for meningiomas (v2021.1)
Nassiri, Farshad , Wang, Justin Z. , Jenkinson, Michael D. , Drummond, Kate, Zhou, Yueren , Snyder, James M. , Santarius, Thomas , Suppiah, Suganth , Poisson, Laila , Gaillard, Francesco, Rosenthal, Mark , Tsang, Derek S. , Aldape, Kenneth , Zadeh, Gelareh , Kaufmann, Timothy, Snyder, James , Au, Karolyn , Barnholtz‐Sloan, Jill S. , Brastianos, Priscilla K. , Gaillard, Francesco, Kaufmann, Timothy J.

Mayo Clinic

Neuro-Oncology | November 15, 2021 | Volume: 24 | Issue: 5 | Pages: 683-693

10.1093/neuonc/noab259 | PMID 34791428 Get It

AbstractBackgroundWith increasing molecular analyses of meningiomas, there is a need to harmonize language used to capture clinical data across centers to ensure that molecular alterations are appropriately linked to clinical variables of interest. Here the International Consortium on Meningiomas presents a set of core and supplemental meningioma-specific common data elements (CDEs) to facilitate comparative and pooled analyses.MethodsThe generation of CDEs followed the 4-phase process similar to other National Institute of Neurological Disorders and Stroke (NINDS) CDE projects: discovery, internal validation, external validation, and distribution.ResultsThe CDEs were organized into patient- and tumor-level modules. In total, 17 core CDEs (10 patient level and 7 tumor level) as well as 14 supplemental CDEs (7 patient level and 7 tumor level) were defined and described. These CDEs are now made publicly available for dissemination and adoption.ConclusionsCDEs provide a framework for discussion in the neuro-oncology community that will facilitate data-sharing for collaborative research projects and aid in developing a common language for comparative and pooled analyses. The meningioma-specific CDEs presented here are intended to be dynamic parameters that evolve with time and The Consortium welcomes international feedback for further refinement and implementation of these CDEs.
Imaging and diagnostic advances for intracranial meningiomas
Huang, Raymond Y. , Fougère, Christian la , Vogelbaum, Michael A. , Wen, Patrick Y, Aldape, Kenneth , Nassiri, Farshad , Zadeh, Gelareh , Dunn, Ian F. , Au, Karolyn , Barnhartz-Sloan, Jill, Bi, Wenya Linda, Brastianos, Priscilla K. , Butowski, Nicholas , Carlotti, Carlos Gilberto , Goldbrunner, Roland , Hashizume, Rintaro , Hanemann, C. Oliver , James, David, Jenkinson, Michael D. , Jungk, Christine, Kaufman, Timothy J, Krischek, Boris , Lee, Ian , Liu, Jeff C. , Mamatjan, Yasin , Mansouri, Alireza , Mawrin, Christian , Ng, Ho‐Keung , Pirouzmand, Farhad , Poisson, Laila , Pollo, Bianca , Raleigh, David R. , Sahm, Felix , Saladino, Andrea , Schichor, Christian , Selman, Warren R., Sloan, Andrew E. , Spears, Julian , Snyder, James , Suppiah, Suganth , Tabatabai, Ghazaleh , Tatagiba, Marcos , Tirapelli, Daniela Pretti da Cunha , Tsang, Derek S. , Deimling, Andreas von , Wen, Patrick Y, Walbert, Tobias , Westphal, Manfred , Workewych, Adriana M , Mansouri, Alireza , von Deimling, Andreas , Sahm, Felix , Huang, Raymond , Lee, Ian Y , Bi, Wenya Linda , Griffith, Brent D , Kaufmann, Timothy J. , Schmidt, Nils Ole , Tonn, Joerg-Christian , Wen, Patrick Yung , Cusimano, Michael D. , DiMeco, Francesco , Drummond, Katharine Jann , Galanis, Evanthia , Giannini, Caterina , Herold‐Mende, Christel C. , Horbinski, Craig , Jungk, Christine, Lachance, Daniel Honore , McDermott, Michael , Muñoz, David G. , Noushmehr, Houtan , Perry, Arie , Santarius, Thomas , Schultz, David , Hanemann, C Oliver , Mamatjan, Yasin , Tatagiba, Marcos

Mayo Clinic

Neuro-Oncology | October 18, 2018 | Volume: 21 | Issue: Supplement_1 | Pages: i44-i61

10.1093/neuonc/noy143 | PMID 30649491 Get It

First Genome-Wide Association Study of Latent Autoimmune Diabetes in Adults Reveals Novel Insights Linking Immune and Metabolic Diabetes
Cousminer, Diana L. , Ahlqvist, Emma , Mishra, Rajashree, Andersen, Mette K. , Chesi, Alessandra , Hawa, M. I., Davis, Asa K., Hodge, Kenyaita M., Bradfield, Jonathan P., Zhou, Kaixin , Guy, Vanessa C., Åkerlund, Mikael, Wod, Mette , Fritsche, Lars G. , Vestergaard, Henrik , Snyder, James W. , Højlund, Kurt , Linneberg, Allan , Käräjämäki, Annemari , Brandslund, Ivan , Kim, Cecilia E, Witte, Daniel R. , Sørgjerd, Elin Pettersen , Brillon, David J., Pedersen, Oluf , Beck‐Nielsen, Henning , Grarup, Niels , Rickels, Michael R. , Melander, Olle , Harris, Ronald I., Varvel, Stephen A. , Grill, Valdemar , Håkonarson, Håkon , Froguel, Philippe , Lonsdale, John T., Mauricio, Dı́dac , Schloot, Nanette C. , Khunti, Kamlesh , Greenbaum, Carla J. , Åsvold, Bjørn Olav , Yderstræde, Knud Bonnet , Pearson, Ewan R. , Schwartz, Stanley S. , Voight, Benjamin F. , Hansen, Torben , Tuomi, Tiinamaija , Boehm, Bernhard O. , Groop, Leif , Leslie, Richard David , Grant, Struan F.A. , Study, Bone Mineral Density in Childhood, Mitchell, Jonathan A. , Lappe, Joan M. , Gilsanz, Vicente , Rickels, Michael R , Vella, Adrian , Hakonarson, Hakon , Mauricio, Didac , Schloot, Nanette C , Khunti, Kamlesh , Greenbaum, Carla J , Hansen, Torben , Tuomi, Tiinamaija , Leslie, R David , Froguel, Phillippe , Grant, Struan F A , Ahlqvist, Emma , Snyder, James, Pratley, Richard E. , Vella, Adrian , Ovalle, Fernando , Lonsdale, John T., Study, Bone Mineral Density in Childhood, McCormack, Shana Erin , Kelly, Andrea True , Kalkwarf, Heidi J. , Shepherd, John , Oberfield, Sharon E. , Zemel, Babette S.

Mayo Clinic

Diabetes Care | September 25, 2018 | Volume: 41 | Issue: 11 | Pages: 2396-2403

10.2337/dc18-1032 | PMID 30254083 Get It

OBJECTIVELatent autoimmune diabetes in adults (LADA) shares clinical features with both type 1 and type 2 diabetes; however, there is ongoing debate regarding the precise definition of LADA. Understanding its genetic basis is one potential strategy to gain insight into appropriate classification of this diabetes subtype.RESEARCH DESIGN AND METHODSWe performed the first genome-wide association study of LADA in case subjects of European ancestry versus population control subjects (n = 2,634 vs. 5,947) and compared against both case subjects with type 1 diabetes (n = 2,454 vs. 968) and type 2 diabetes (n = 2,779 vs. 10,396).RESULTSThe leading genetic signals were principally shared with type 1 diabetes, although we observed positive genetic correlations genome-wide with both type 1 and type 2 diabetes. Additionally, we observed a novel independent signal at the known type 1 diabetes locus harboring PFKFB3, encoding a regulator of glycolysis and insulin signaling in type 2 diabetes and inflammation and autophagy in autoimmune disease, as well as an attenuation of key type 1–associated HLA haplotype frequencies in LADA, suggesting that these are factors that distinguish childhood-onset type 1 diabetes from adult autoimmune diabetes.CONCLUSIONSOur results support the need for further investigations of the genetic factors that distinguish forms of autoimmune diabetes as well as more precise classification strategies.
Advances in multidisciplinary therapy for meningiomas
Brastianos, Priscilla K. , Butowski, Nicholas , Chan, Jason W., Dunn, Ian F. , Goldbrunner, Roland , Ippen, Franziska M. , Mawrin, Christian , Sloan, Andrew E. , Snyder, James , Tabatabai, Ghazaleh , Tatagiba, Marcos, Wen, Patrick Y. , Aldape, Kenneth, Nassiri, Farshad , Zadeh, Gelareh , Jenkinson, Michael D. , Raleigh, David R. , Au, Karolyn , Barnhartz-Sloan, Jill, Butowski, N, Carlotti, Carlos Gilberto , Griffith, Brent, Hashizume, Rintaro , Hanemann, C. Oliver , Huang, Raymond Y. , Jungk, Christine, Kaufman, Timothy J, Krischek, Boris , Lee, Ian , Liu, Jeff C. , Mamatjan, Yasin , Mansouri, Alireza , Ng, Ho‐Keung , Pirouzmand, Farhad , Poisson, Laila , Pollo, Bianca , Sahm, Felix , Saladino, Andrea , Santarius, Thomas , Schichor, Christian , Selman, Warren R., Spears, Julian , Suppiah, Suganth , Tatagiba, Marcos, Tirapelli, Daniela, Tsang, Derek S. , Vogelbaum, Michael A. , Deimling, Andreas von , Walbert, Tobias , Westphal, Manfred , Workewych, Adriana M , Tatagiba, Marcos , Galanis, Evanthia , Mansouri, Alireza , von Deimling, Andreas , Sahm, Felix , Huang, Raymond , Lee, Ian Y , Herold‐Mende, Christel C. , McDermott, Michael , Tatagiba, Marcos , Tonn, Joerg-Christian , Wen, Patrick Yung , Bi, Wenya Linda , Cusimano, Michael D. , DiMeco, Francesco , Drummond, Katharine Jann , Giannini, Caterina , Horbinski, Craig , James, David, Jungk, Christine, Lachance, Daniel Honore , Fougère, Christian la , Muñoz, David G. , Noushmehr, Houtan , Perry, Arie , Schultz, David , Schmidt, Nils Ole , Hanemann, C Oliver , Mamatjan, Yasin

Mayo Clinic

Neuro-Oncology | September 17, 2018 | Volume: 21 | Issue: Supplement_1 | Pages: i18-i31

10.1093/neuonc/noy136 | PMID 30649489 Get It

A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2018 Update by the Infectious Diseases Society of America and the American Society for Microbiologya
Binnicker, Matthew J. , Campbell, Sheldon , Chapin, Kimberle C. , Gilligan, Peter H., Gonzalez, Mark D. , Jerris, Robert C. , Kehl, Sue C., Patel, Robin , Pritt, Bobbi S. , Richter, Sandra S. , Robinson-Dunn, Barbara, Schwartzman, Joseph D., Snyder, James W. , Telford, Sam R. , Theel, Elitza S. , Thomson, Richard B., Weinstein, Melvin P., Yao, Joseph D. , Patel, Robin , Pritt, Bobbi S , Miller, J. Michael , Carroll, Karen C.

Mayo Clinic

Clinical Infectious Diseases | August 31, 2018 | Volume: 67 | Issue: 6 | Pages: 813-816

10.1093/cid/ciy584 | PMID 30169655 Get It

Abstract The critical nature of the microbiology laboratory in infectious disease diagnosis calls for a close, positive working relationship between the physician/advanced practice provider and the microbiologists who provide enormous value to the healthcare team. This document, developed by experts in laboratory and adult and pediatric clinical medicine, provides information on which tests are valuable and in which contexts, and on tests that add little or no value for diagnostic decisions. This document presents a system-based approach rather than specimen-based approach, and includes bloodstream and cardiovascular system infections, central nervous system infections, ocular infections, soft tissue infections of the head and neck, upper and lower respiratory infections, infections of the gastrointestinal tract, intra-abdominal infections, bone and joint infections, urinary tract infections, genital infections, and other skin and soft tissue infections; or into etiologic agent groups, including arthropod-borne infections, viral syndromes, and blood and tissue parasite infections. Each section contains introductory concepts, a summary of key points, and detailed tables that list suspected agents; the most reliable tests to order; the samples (and volumes) to collect in order of preference; specimen transport devices, procedures, times, and temperatures; and detailed notes on specific issues regarding the test methods, such as when tests are likely to require a specialized laboratory or have prolonged turnaround times. In addition, the pediatric needs of specimen management are also emphasized. There is intentional redundancy among the tables and sections, as many agents and assay choices overlap. The document is intended to serve as a guidance for physicians in choosing tests that will aid them to quickly and accurately diagnose infectious diseases in their patients.
A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2018 Update by the Infectious Diseases Society of America and the American Society for Microbiologya
Binnicker, Matthew J. , Campbell, Sheldon , Chapin, Kimberle C. , Gilligan, Peter H., Gonzalez, Mark D. , Jerris, Robert C. , Kehl, Sue C., Patel, Robin , Pritt, Bobbi S. , Richter, Sandra S. , Robinson-Dunn, Barbara, Schwartzman, Joseph D., Snyder, James W. , Telford, Sam R. , Theel, Elitza S. , Thomson, Richard B., Weinstein, Melvin P., Yao, Joseph D. , Patel, Robin , Pritt, Bobbi S , Miller, J. Michael , Carroll, Karen C.

Mayo Clinic

Clinical Infectious Diseases | April 30, 2018 | Volume: 67 | Issue: 6 | Pages: e1-e94

10.1093/cid/ciy381 | PMID 29955859 Get It

Abstract The critical nature of the microbiology laboratory in infectious disease diagnosis calls for a close, positive working relationship between the physician/advanced practice provider and the microbiologists who provide enormous value to the healthcare team. This document, developed by experts in laboratory and adult and pediatric clinical medicine, provides information on which tests are valuable and in which contexts, and on tests that add little or no value for diagnostic decisions. This document presents a system-based approach rather than specimen-based approach, and includes bloodstream and cardiovascular system infections, central nervous system infections, ocular infections, soft tissue infections of the head and neck, upper and lower respiratory infections, infections of the gastrointestinal tract, intra-abdominal infections, bone and joint infections, urinary tract infections, genital infections, and other skin and soft tissue infections; or into etiologic agent groups, including arthropod-borne infections, viral syndromes, and blood and tissue parasite infections. Each section contains introductory concepts, a summary of key points, and detailed tables that list suspected agents; the most reliable tests to order; the samples (and volumes) to collect in order of preference; specimen transport devices, procedures, times, and temperatures; and detailed notes on specific issues regarding the test methods, such as when tests are likely to require a specialized laboratory or have prolonged turnaround times. In addition, the pediatric needs of specimen management are also emphasized. There is intentional redundancy among the tables and sections, as many agents and assay choices overlap. The document is intended to serve as a guidance for physicians in choosing tests that will aid them to quickly and accurately diagnose infectious diseases in their patients.
Executive Summary: A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2013 Recommendations by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)a
Baron, Ellen Jo , Weinstein, Melvin P., Richter, Sandra S. , Gilligan, Peter H., Thomson, Richard B., Bourbeau, Paul, Kehl, Sue C., Robinson-Dunn, Barbara, Schwartzman, Joseph D., Chapin, Kimberle, Snyder, James W. , Forbes, Betty A., Patel, Robin , Rosenblatt, Jon E., Pritt, Bobbi S. , Miller, J. Michael , Carroll, Karen C. , Dunne, William Michael , Patel, Robin , Pritt, Bobbi S

Mayo Clinic

Clinical Infectious Diseases | July 23, 2013 | Volume: 57 | Issue: 4 | Pages: 485-488

10.1093/cid/cit441 | PMID 23881727 Get It

Abstract The critical role of the microbiology laboratory in infectious disease diagnosis calls for a close, positive working relationship between the physician and the microbiologists who provide enormous value to the health care team. This document, developed by both laboratory and clinical experts, provides information on which tests are valuable and in which contexts, and on tests that add little or no value for diagnostic decisions. Sections are divided into anatomic systems, including Bloodstream Infections and Infections of the Cardiovascular System, Central Nervous System Infections, Ocular Infections, Soft Tissue Infections of the Head and Neck, Upper Respiratory Infections, Lower Respiratory Tract infections, Infections of the Gastrointestinal Tract, Intraabdominal Infections, Bone and Joint Infections, Urinary Tract Infections, Genital Infections, and Skin and Soft Tissue Infections; or into etiologic agent groups, including Tickborne Infections, Viral Syndromes, and Blood and Tissue Parasite Infections. Each section contains introductory concepts, a summary of key points, and detailed tables that list suspected agents; the most reliable tests to order; the samples (and volumes) to collect in order of preference; specimen transport devices, procedures, times, and temperatures; and detailed notes on specific issues regarding the test methods, such as when tests are likely to require a specialized laboratory or have prolonged turnaround times. There is redundancy among the tables and sections, as many agents and assay choices overlap. The document is intended to serve as a reference to guide physicians in choosing tests that will aid them to diagnose infectious diseases in their patients.
A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2013 Recommendations by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)a
Baron, Ellen Jo , Weinstein, Melvin P., Richter, Sandra S. , Gilligan, Peter H., Thomson, Richard B., Bourbeau, Paul, Kehl, Sue C., Robinson-Dunn, Barbara, Schwartzman, Joseph D., Chapin, Kimberle, Snyder, James W. , Forbes, Betty A., Patel, Robin , Rosenblatt, Jon E., Pritt, Bobbi S. , Miller, J. Michael , Carroll, Karen C. , Dunne, William Michael , Patel, Robin , Pritt, Bobbi S

Mayo Clinic

Clinical Infectious Diseases | July 11, 2013 | Volume: 57 | Issue: 4 | Pages: e22-e121

10.1093/cid/cit278 | PMID 23845951 Get It

Abstract The critical role of the microbiology laboratory in infectious disease diagnosis calls for a close, positive working relationship between the physician and the microbiologists who provide enormous value to the health care team. This document, developed by both laboratory and clinical experts, provides information on which tests are valuable and in which contexts, and on tests that add little or no value for diagnostic decisions. Sections are divided into anatomic systems, including Bloodstream Infections and Infections of the Cardiovascular System, Central Nervous System Infections, Ocular Infections, Soft Tissue Infections of the Head and Neck, Upper Respiratory Infections, Lower Respiratory Tract infections, Infections of the Gastrointestinal Tract, Intraabdominal Infections, Bone and Joint Infections, Urinary Tract Infections, Genital Infections, and Skin and Soft Tissue Infections; or into etiologic agent groups, including Tickborne Infections, Viral Syndromes, and Blood and Tissue Parasite Infections. Each section contains introductory concepts, a summary of key points, and detailed tables that list suspected agents; the most reliable tests to order; the samples (and volumes) to collect in order of preference; specimen transport devices, procedures, times, and temperatures; and detailed notes on specific issues regarding the test methods, such as when tests are likely to require a specialized laboratory or have prolonged turnaround times. There is redundancy among the tables and sections, as many agents and assay choices overlap. The document is intended to serve as a reference to guide physicians in choosing tests that will aid them to diagnose infectious diseases in their patients.